McGrattan 2021

Study ID(s) and Acronym(s)
NCT03265522 / NCT03569319 / THINK-MED
Current Status of Trial
Completed
Study Aim
Treatment MCI
Study Design
RCT
Blinding
No blinding
Intervention type
Non-pharmacological
Intervention
Dietary education
Health Status/Diagnosis
Mild Cognitive Impairment (MCI)
Key Points
"a total of 20 participants (n = 15 MCI; n = 5 SCI) were enrolled in the THINK-MED study. However, there were 10 (50%) participants (n = 9 MCI; n = 1 SCI) who withdrew from the study. Although, those who remained in the intervention rated and evaluated their experience as generally positive, recruitment and retention, especially from a MCI population, was extremely challenging. This highlights the complex needs of this heterogeneous clinical cohort. Recruiting participants from a community-based sample with SCI was more feasible, reaching a wider audience in a shorter time period. There were challenges relating to data collection and incompleteness, with the occurrence of missing data particularly among the questionnaire-based assessments." McGrattan 2021